Hudson Bay Capital Management’s Dynavax Technologies DVAX Stock Holding History

Hudson Bay Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-550,000	Closed	-$8.46M	–	1452
2025 Q4	$8.46M	Sell	550,000 -54,825	-9%	-$604K	0.03%	374
2025 Q3	$6.01M	Buy	604,825 +63,225	+12%	+$658K	0.02%	500
2025 Q2	$5.37M	Buy	541,600 +171,700	+46%	+$1.81M	0.02%	531
2025 Q1	$4.8M	Sell	369,900 -129,800	-26%	-$1.72M	0.01%	604
2024 Q4	$6.38M	Sell	499,700 -140,900	-22%	-$1.7M	0.02%	454
2024 Q3	$7.14M	Buy	640,600 +250,600	+64%	+$2.76M	0.03%	355
2024 Q2	$4.38M	Buy	390,000 +90,000	+30%	+$1.05M	0.02%	402
2024 Q1	$3.72M	Buy	+300,000	New	+$3.91M	0.02%	365
2017 Q3	–	Sell	-100,000	Closed	-$965K	–	428
2017 Q2	$965K	Buy	+100,000	New	+$649K	0.02%	418

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hudson Bay Capital Management's DVAX Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 550,000 shares — an estimated $8.46M sold.

Hudson Bay Capital Management first reported a position in DVAX in Q2 2017 and held it in 9 quarters. The position peaked at $8.46M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Hudson Bay Capital Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Hudson Bay Capital Management sold 550,000 Dynavax Technologies shares in Q1 2026, an estimated $8.46M.
Hudson Bay Capital Management first reported a position in Dynavax Technologies in Q2 2017 and held it in 9 quarters.
Hudson Bay Capital Management's Dynavax Technologies position peaked at $8.46M in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.